LOGIN  |  REGISTER
Viking Therapeutics
Astria Therapeutics

Modivcare and Jobs & Hope West Virginia Partnership Transforms Lives Across the State

February 12, 2024 | Last Trade: US$11.26 0.13 1.17

CHARLESTON, W. Va. / Feb 12, 2024 / Business Wire / Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, proudly announces its transformative partnership with Governor Jim Justice’s Jobs & Hope West Virginia, aimed at breaking down transportation barriers and fostering recovery and employment opportunities for West Virginians. This collaborative effort has already made a significant impact, changing lives and creating positive outcomes for individuals, families, and communities statewide.

Since the inception of the partnership in November 2020, Modivcare has worked closely with Jobs & Hope WV to provide essential transportation services to program participants. Through this partnership, countless West Virginians have gained access to treatment, employment opportunities, counseling sessions, and educational programs, regardless of their location or destination.

Key aspects of the partnership include:

  • Over 120,000 trip legs covering more than 2.2 million miles
  • Collaboration on unique transportation solutions such as the Get Paid to Pay It Forward program, which offers incentives to combat transportation barriers in substance use treatment
  • Graduation of 495 participants since the launch of the program
  • 5,124 participants Jobs and Hope has helped to employ, with an average salary of $33,398, totaling $17.2 million in combined salaries
  • 1,244 participants no longer in need of SNAP benefits, resulting in an average annual savings of over $4.8 million

“We are incredibly proud of the impact our partnership with Jobs & Hope West Virginia has made on the lives of West Virginians,” says Ilias Simpson, President of Modivcare Mobility. “By eliminating transportation barriers and fostering opportunities for recovery and employment, we are not only transforming individual lives but also contributing to the resilience and prosperity of communities across the state. This partnership exemplifies our commitment to leveraging our resources and expertise to create meaningful change and build a brighter future for all.”

Deb Harris, Manager of West Virginia Schools of Diversion and Transition/Jobs & Hope West Virginia, provided comment.

“Through the Jobs & Hope WV and Modivcare partnership, countless West Virginians now have the means to break free from transportation barriers, changing lives and creating a direct impact on families and communities across the state of West Virginia,” says Harris. “This partnership is just the beginning of a remarkable journey, the collaboration between Jobs & Hope WV and Modivcare holds immense potential. We look forward to the exciting developments and partnerships that will undoubtedly continue to shape the future, impacting lives and communities across West Virginia.”

Modivcare’s commitment to innovation and collaboration with Jobs & Hope WV exemplifies its dedication to improving lives and strengthening communities. This partnership marks the beginning of a transformative journey, with boundless opportunities for positive change in West Virginia.

About Modivcare

Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal and home care, and virtual and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB